Spectral AI, Inc. (MDAI)
NASDAQ: MDAI · Real-Time Price · USD
1.980
+0.020 (1.02%)
At close: Apr 28, 2026, 4:00 PM EDT
2.000
+0.020 (1.01%)
After-hours: Apr 28, 2026, 7:41 PM EDT

Company Description

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.

The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds.

Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images.

Spectral AI, Inc. is headquartered in Dallas, Texas.

Spectral AI, Inc.
Spectral AI logo
Country United States
Founded 2013
Industry Medical Devices
Sector Healthcare
Employees 65
CEO Vincent Capone

Contact Details

Address:
2515 McKinney Avenue, Suite 1000
Dallas, Texas 75201
United States
Phone 972 499 4934
Website spectral-ai.com

Stock Details

Ticker Symbol MDAI
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001833498
CUSIP Number 84757T105
ISIN Number US84757T1051
SIC Code 3841

Key Executives

Name Position
Wensheng Fan Co-Founder, Chief Innovation Strategist and Senior Advisor to the Chief Executive Officer
Vincent Stanley Capone Esq. Chief Executive Officer and Corporate Secretary
Dr. John Michael DiMaio M.D. Founder and Chairman
Stanley Micek Chief Operating Officer
Allison Kumar Head of Regulatory Affairs and Clinical Trials
Louis Percoco General Manager

Latest SEC Filings

Date Type Title
Apr 22, 2026 8-K Current Report
Apr 16, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 16, 2026 DEF 14A Other definitive proxy statements
Apr 8, 2026 8-K Current Report
Apr 6, 2026 PRE 14A Other preliminary proxy statements
Mar 25, 2026 8-K Current Report
Mar 25, 2026 10-K Annual Report
Mar 20, 2026 8-K Current Report
Mar 18, 2026 SCHEDULE 13D/A Filing
Feb 11, 2026 SCHEDULE 13G Filing